News

Drug selection, timing for refractory convulsive status epilepticus need improvement


 

AT AES 2013

Additional analysis from this study could shed more light on methods for improving outcomes. Data from an additional 46 patients are currently being analyzed, Dr. Loddenkemper said.

This study was funded by the American Epilepsy Society Infrastructure Award and the Epilepsy Foundation of America. Dr. Loddenkemper reported receiving research funding from Eisai and Lundbeck.

Pages

Recommended Reading

New psychoactive drug nomenclature system devised
MDedge Neurology
Failure to diagnose
MDedge Neurology
BP therapy didn’t boost survival in ischemic stroke
MDedge Neurology
Cholinesterase inhibitors most effective in mild Alzheimer’s
MDedge Neurology
Subjective memory complaints predict clinical impairment
MDedge Neurology
FDA updates clobazam label to reflect risk of severe skin reactions
MDedge Neurology
Blood pressure control tied to decline in stroke mortality over past 50 years
MDedge Neurology
Pediatric epilepsy surgery improved mood, behavior in some patients
MDedge Neurology
Mild cognitive impairment symptom mimics common before Alzheimer’s diagnosis
MDedge Neurology
VIDEO: Brain's iron levels may be ADHD biomarker
MDedge Neurology